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One of the major roles of professional phagocytes is the removal of dead
cells in the body. We know less about the clearance of necrotic cells than
apoptotic cell phagocytosis, despite the fact that both types of dead cells
need to be cleared together and necrotic cells appear often in pathological
settings. In the present study, we examined phagocytosis of heat- or H2O2-
killed necrotic and apoptotic thymocytes by mouse bone marrow-derived
macrophages (BMDMs) in vitro and found that the two cell types are
engulfed at equal efficiency and compete with each other when added
together to BMDMs. Phagocytosis of both apoptotic and necrotic thymo-
cytes was decreased by (a) blocking phosphatidylserine on the surface of
dying cells; (b) inhibition of Mer tyrosine kinase, Tim-4, integrin b3 recep-
tor signaling, or Ras-related C3 botulinum toxin substrate 1 activity; or (c)
using BMDMs deficient for transglutaminase 2. Stimulation of liver X,
retinoid X, retinoic acid or glucocorticoid nuclear receptors in BMDMs
enhanced not only apoptotic, but also necrotic cell uptake. Electron micro-
scopic analysis of the engulfment process revealed that the morphology of
phagosomes and the phagocytic cup formed during the uptake of dying
thymocytes is similar for apoptotic and necrotic cells. Our data indicate
that apoptotic and necrotic cells are cleared via the same mechanisms, and
removal of necrotic cells in vivo can be facilitated by molecules known to
enhance the uptake of apoptotic cells.
Every day billions of damaged or senescent cells die in
our body and are replaced with new cells [1]. One of
the physiological cell death types is apoptosis charac-
terized by detachment and shrinkage of the cell,
condensation and fragmentation of nuclear content [2],
maintenance of membrane integrity and display of ‘eat
me’ signals such as phosphatidylserine (PS) [3], or
disappearance of so-called ‘don’t eat me’ signals, such
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as cluster of differentiation (CD) 47 on the apoptotic
cell surface [4]. Apoptosis can be activated by a wide
range of stimuli, which trigger either the cell death
receptor or the mitochondrial pathway of apoptosis
[5,6]. Apoptosis is considered an immunologically
silent process, since not only do apoptotic cells fail to
induce inflammation, but uptake of apoptotic cells was
shown to actively suppress the inflammatory program
in engulfing macrophages [7,8]. In contrast to apopto-
sis, necrosis is characterized by swelling of the cell and
early membrane rupture [9] leading to release of the
intracellular content, which can damage the surround-
ing tissues and initiate local inflammation [10–12]. Sev-
eral conditions can result in necrosis, such as exposure
of cells to high temperature in burns, physical damage,
hypoxia, viral infection or in the case of programmed
necroptosis, cell death receptor ligation [13]. Necrotic
cells were also shown to display PS on their outer
membrane leaflet, which is used for their uptake
[14,15]. Similar to apoptotic cells, engagement of PS
receptors on the surface of macrophages elicits an
anti-inflammatory response, but this effect is overrid-
den by the noxious cell content released during cell
necrosis [14,16,17]. Efficient clearance of necrotic cells
in the organism helps to resolve the wounded area and
the initiated inflammation. Apoptotic cells can also
lose membrane integrity and undergo secondary necro-
sis in cases in which they are not cleared from the tis-
sues properly [18]. In this case, the accumulating
secondary necrotic cells initiate local inflammation,
which can lead to the development of autoimmune
diseases in the long term [19,20].
Macrophages are considered to be the primary
phagocytes responsible for clearing dead cells in most
organs. Macrophages are equipped with a battery of
receptors to recognize, bind and engulf apoptotic cells.
Among others, these receptors include the direct PS
receptor T-cell immunoglobulin mucin receptor 4
(Tim-4), stabilin-2, brain-specific angiogenesis inhibitor
1, and receptors, such as Mer tyrosine kinase
(MerTK), integrin avb3 and its co-receptor transglu-
taminase 2 (TG2), that bind to PS through various
bridging molecules [21]. Interestingly, the CD36–avb3
integrin receptor complex was reported to recognize
and bind externalized PS during necrotic cell uptake as
well [16]. The phagocytic receptors participating in the
uptake of apoptotic cells activate two evolutionarily
conserved signaling pathways, both of which trigger
the activity of the small G protein Rac that regulates
actin reorganization and lamellipodia formation during
phagocytosis [22]. Despite the shared integrin receptors
considerable differences were found in the uptake of
the two cell types. On one hand, it was suggested that
necrotic cells compete with apoptotic ones much more
efficiently than the other way around [14], though sur-
prisingly apoptotic cells are engulfed more quickly
than necrotic ones [17]. On the other, in sharp con-
trast, it was indicated by another laboratory that
macrophages have distinct modes for apoptotic and
necrotic cell recognition, and they do not compete with
each other upon simultaneous exposure [23]. While
uptake of apoptotic cells takes place via well-defined
portals in macrophages, where phagocytic receptors
assemble together to mediate efficient uptake of a
number of dead cells into tight-fitting phagosomes
[24], necrotic cell phagocytosis seems to take place via
a macropinocytosis-like process generating spacious
macropinosomes and an abundant number of pseu-
dopods [25]. Activation of nuclear receptor liver X
(LXR), retinoic acid (RAR), retinoid X (RXR) [26]
and glucocorticoid (GR) receptors [26–28] in macro-
phages leads to upregulation of several of the above-
mentioned apopto-phagocytic genes and results in
enhanced apoptotic cell clearance.
While we consider apoptosis and necrosis as two dif-
ferent cell death forms, under pathological conditions
they very often appear together and have to be cleared
simultaneously [29–34]. Thus in this study, we decided
to reinvestigate the mechanism and preference in the
uptake of apoptotic and necrotic cells by studying the
engulfment of serum-starved apoptotic and heat- or
H2O2-killed necrotic thymocytes by bone marrow-
derived macrophages (BMDMs). Our data indicate
that apoptotic and heat- or H2O2-treated necrotic thy-
mocytes are cleared by macrophages via similar PS-
dependent mechanisms and this clearance can be
enhanced by nuclear receptor agonists known to
induce apoptotic cell phagocytosis. In addition, the
necrotic and apoptotic cells are engulfed at equal effi-
ciency and compete with each other suggesting similar
uptake mechanisms.
Materials and methods
Reagents
All reagents were obtained from Sigma-Aldrich (Budapest,
Hungary) except when indicated otherwise.
Experimental animals
The experiments were carried out with 4-week-old or 2- to
4-month-old C57B6 mice. In some experiments, TG2+/+
and TG2/ mice were used. Mice were maintained in
specific pathogen-free conditions in the Central Animal
Facility and all animal experiments were approved by the
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Animal Care and Use Committee of University of Debre-
cen (DEMAB).
BMDM cell culture and treatment
Bone marrow progenitors were obtained from the femurs
of 2- to 4-month-old mice. Femurs were washed with sterile
physiological saline. Cells were allowed to differentiate for
6 days in DMEM supplemented with 10% FBS, 10% con-
ditioned medium derived from L929 cells as a source of
macrophage colony-stimulating factor, 2 mM glutamine,
100 UmL1 penicillin and 100 mgmL1 streptomycin at
37 °C in 5% CO2. Non-adherent cells were washed away
after 3 days. BMDMs were treated with the RAR agonist
all-trans retinoic acid (ATRA; 1 lM), the RXR agonist
9-cis retinoic acid (9cRA; 1 lM), the LXR agonist GW3965
(Tocris, Bioscience, Bristol, UK; 1 lM) or the GR agonist
dexamethasone acetate (1 lM) to activate nuclear receptors,
or vehicle (0.5% DMSO) for 24 h. In the inhibitory experi-
ments, 1 lM BMS777607 Tyro3, Axl, Mer (TAM) receptor
tyrosine kinase inhibitor or 100 lM NSC23766 small GTP
binding protein Ras-related C3 botulinum toxin substrate 1
(Rac1) inhibitor (Tocris) was used for 24 h. For blocking
integrins, either 2 mgmL1 arginylglycylaspartic acid
(RGD) peptide or 4 lgmL1 fluorescein isothiocyanate
hamster anti-mouse CD61 antibody (BD Biosciences,
Franklin Lakes, NJ, USA) was used for 1 h before
addition of the apoptotic or necrotic cells. Four micro-
grams per milliliter Tim-4 monoclonal antibody [54
(RMT4-54)], phycoerythrin (Thermo Fisher Scientific, Wal-
tham, MA, USA) was used for 1 h to block the PS recep-
tor Tim-4 on the surface of BMDMs.
Apoptosis and necrosis induction and PS
masking on thymocytes
Thymi were collected from 4-week-old C57B6 mice, and
thymocytes were isolated and cultured for 24 h
(107 cellsmL1) in DMEM supplemented with 2 mM glu-
tamine, 100 UmL1 penicillin, and 100 mgmL1 strepto-
mycin. To avoid potential effects of apoptosis inducers on
the uptake of apoptotic cells, apoptosis of thymocytes was
induced by growth factor withdrawal [35] by incubating the
cells in serum-free medium for 24 h, as we described previ-
ously [36]. To generate necrotic target cells, thymocytes
were incubated either at 55 °C for 20 min [23] or with
1 mM H2O2 for 24 h [37]. Since isolated thymocytes show
spontaneous cell death after 24 h of incubation [38], freshly
isolated thymocytes were used as living cell controls in the
experiments. Propidium iodide/annexin V labeling was used
to determine the percentage of apoptotic and necrotic cells
and transmission electron microscopy was used to confirm
the cell death mechanism (Fig. 1A–D). Ten micromolar
carboxyfluorescein diacetate succinimidyl ester (CFDA-SE;
Fig. 1. Morphology and viability of target cells. Transmission electron microscopic images and propidium iodide/annexin V staining of target
cells. (A) Thymocytes immediately after isolation are considered as viable cells. (B) Apoptosis induced by serum deprivation for 24 h is
characterized with condensed nuclei. According to the propidium iodide staining, both early and late apoptotic cells are included. (C,D)
Incubation at 55 °C for 20 min (C) or with 1 mM H2O2 for 24 h (D) induced necrosis with early swelling and propidium iodide positivity.
Scale bar: 2 lm.
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Thermo Fisher Scientific) or 0.5 lM Cell Tracker deep red
dye (Thermo Fisher Scientific) was used to label apoptotic
and necrotic cells as indicated below. PS was blocked by
Alexa Fluor 647-conjugated annexin V (Thermo Fisher
Scientific) on the surface of apoptotic and necrotic thymo-
cytes.
In vitro phagocytosis assay
BMDMs were plated in 24-well plates (3 9 105/well) and
co-incubated with fluorescently stained apoptotic or necro-
tic cells (CFDA-SE, deep red). Thymocytes were added to
the BMDMs at the indicated (dead cells per macrophage)
ratios. Since 100% of heat- or H2O2-treated cells were
necrotic, but in the apoptotic samples 30–40% cells were
living, before the phagocytosis experiments we verified the
viability stage of the apoptotic and necrotic cell population
and normalized the target cell number to have the same
amount of apoptotic and necrotic cells during phagocytosis
assays. Phagocytosis was allowed to proceed for the indi-
cated time periods at 37 °C. After coculture, thymocytes
were washed away extensively and macrophages were
detached by trypsinization. Percentage of macrophages
engulfing dead cells was determined on a BD Biosciences
FACSCalibur flow cytometer. In competition experiments
differently stained apoptotic (CFDA-SE) and necrotic (deep
red) thymocytes were added together at different ratios
(1 : 1, 1 : 3, 1 : 6, 1 : 9) to macrophages. For determining
phagocytic preference, macrophages were exposed to
stained (CFDA-SE) apoptotic or necrotic thymocytes for
30 min, and then were further exposed to labeled apoptotic
or necrotic cells. After coculture, thymocytes were washed
away extensively and macrophages were detached by
trypsinization. Percentage of macrophages engulfing dead
cells was analyzed on a FACSCalibur flow cytometer.
Laser scanning cytometry
BMDMs were plated into (IBIDI, Madison, WI, USA)
eight-well chamber slides (30 000 macrophages per well)
and were stained with Hoechst 33342. Fluorescently
labelled apoptotic (CFDA-SE) and necrotic (deep red) thy-
mocytes were added into the BMDMs immediately before
the measurement. During the measurement, cells were kept
in an IBIDI incubator at 37 °C with 5% CO2 air and 90%
humidity. Images were made using an Olympus (Tokyo,
Japan) IX-71 inverted microscope and a video file was gen-
erated from these images using IMAGEJ software (NIH,
Bethesda, MD, USA).
Confocal microscopy
Prior to measurement BMDMs were plated into IBIDI
eight-well chamber slides (30 000 macrophages per well)
and were stained with (5-(and-6)-(((4-chloromethyl)benzoyl)
amino)tetramethylrhodamine (CMTMR); Thermo Fisher
Scientific). Fluorescently labelled apoptotic (CFDA-SE)
and necrotic (deep red) thymocytes were added into the
BMDMs immediately before the measurement. Time-lapse
movies were made using Zeiss (Oberkochen, Germany)
LSM510 confocal laser scanning microscope. Images were
taken every 10 s at 140 nm per pixel resolution. The region
of interest was extracted and exported with 16 framess1
speed, yielding a compressed video 160 times the actual
speed of the process of phagocytosis.
Transmission electron microscopy
For transmission electron microscopy apoptotic and necro-
tic thymocytes were collected and subsequently fixed with
1% glutaraldehyde in 0.1 M cacodylate buffer, and post-
fixed with 2% OsO4 in the same buffer. For analysis of
phagocytosis, 5-day-old BMDMs on a glass slide were fed
with apoptotic and necrotic thymocytes for 30 min and
subsequently fixed with 1% glutaraldehyde in 0.1 M
cacodylate buffer, and postfixed with 2% OsO4 in the same
buffer. Slide samples were then dehydrated and stained
with uranyl acetate and lead citrate and observed under a
Zeiss EM900 electron microscope.
Statistical analyses
All the data are representative of at least three independent
experiments. Values are expressed as mean  SD. Statisti-
cal analysis was performed using an unpaired Student’s
t test.
Results and Discussion
The uptake of both apoptotic and necrotic cells
is PS-, MerTK-, Tim-4-, integrin b3- and TG2-
dependent
The exposure of PS on the surface of apoptotic cells is
an important primary signal recognized by phagocytes.
Our results using the high-affinity PS-binding protein
annexin V labeling confirmed the results from others
that PS appeared on the surface of both heat-killed
and H2O2-exposed thymocytes (Fig. 1). Thus, we
decided to test whether the uptake of apoptotic and
necrotic thymocytes is dependent on PS via performing
blocking experiments with annexin V. Masking of PS
on the surface of necrotic and apoptotic thymocytes
by recombinant annexin V treatment significantly
decreased the uptake of both cell types (Fig. 2A) indi-
cating a role of PS in the phagocytosis of necrotic and
apoptotic cells. Previously, we detected the expression
of several phagocytic receptors (integrin av, b1, b3, b5,
MerTK, Tim-4, Stabilin-2, CD14, and CD36) in
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mouse BMDMs [26]. Among these, thrombospondin–
CD36–avb3 complex, CD14, and CD36 were already
demonstrated to participate in the necrotic cell uptake
as well [20].
In our experiments, we aimed to test the require-
ment for the other PS-dependent receptors in the
necrotic cell uptake. MerTK is a member of the TAM
family of receptor tyrosine kinases and can bind the
PS indirectly via bridging molecules (e.g. growth arrest
specific 6, protein S) [39,40]. Inhibition of MerTK by
using the BMS777607 TAM receptor tyrosine kinase
inhibitor in BMDMs resulted in 50% reduction of
both necrotic and apoptotic thymocyte uptake
(Fig. 2B). We also tested the involvement of the direct
PS receptor Tim-4 in necrotic cell uptake by blocking
the receptor with an anti-Tim-4 antibody and observed
a similarly decreased necrotic and apoptotic thymocyte
uptake (Fig. 2C). avb3 integrin receptors also can rec-
ognize PS on the surface of apoptotic and necrotic
cells in an indirect way with the help of bridging mole-
cules [e.g. milk fat globule-EGF factor 8 protein
(MFG-E8)] [41]. Blockade of receptor avb3 function by
RGD peptides or by an anti-mouse CD61 antibody
resulted in an effective inhibition of the uptake of both
apoptotic and necrotic thymocytes by BMDMs
(Fig. 2D). Previously we have reported that TG2 can
act as a b3 integrin co-receptor in the context of
MFG-E8 binding; thus, it can contribute to the proper
phagocytosis of apoptotic cells [24]. Using BMDMs
derived from TG2/ mice, we again observed a simi-
lar reduction in the uptake of apoptotic and necrotic
cells (Fig. 2E). Altogether, our observations indicate
that the same PS-recognizing receptors participate in
the uptake of apoptotic and primary necrotic cells.
Triggering of various nuclear receptors enhances
the phagocytosis of both apoptotic and necrotic
cells
Previously we have demonstrated that during engulf-
ment the lipid content of apoptotic cells triggers the
LXR receptor of the macrophage which, in response,
upregulates the expression of MerTK and retinaldehyde
dehydrogenases leading to retinoid synthesis, which
then contributes to the upregulation of further phago-
cytic receptors and finally results in enhanced apoptotic
Fig. 2. PS-dependent mechanisms participate in the uptake of both apoptotic and primary necrotic cells. (A) Phagocytosis of control or
recombinant annexin V-exposed fluorescently labeled apoptotic or necrotic thymocytes by BMDMs added in 5 : 1 target cell : macrophage
ratio. (B–E) Phagocytosis of fluorescently labelled apoptotic or necrotic thymocytes added to BMDMs in 5 : 1 target cell : macrophage ratio
after treating macrophages with 1 lM BMS777607 TAM kinase inhibitor (B) for 24 h, or in the presence of 4 lgmL1 anti-Tim-4 antibody
(C), 4 lgmL1 anti-integrin b3 antibody or 2 mgmL1 RGD peptide (D). (E) Phagocytosis by macrophages derived from TG2 knockout mice
was also tested. Apoptosis and necrosis were induced as described in Materials and methods. Phagocytosis was allowed for 60 min.
Results are expressed as mean  SD of three independent experiments (*significantly different from its own control, P < 0.05 determined
by unpaired Student’s t test). ns: not significant; MUs: macrophages.
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cell engulfment [26]. The retinoid-dependent phagocytic
receptors included TG2, Tim-4, and stabilin-2 in
BMDMs. In addition, it was also demonstrated that
activation of the GR also leads to an enhanced apop-
totic cell uptake mainly via MerTK-dependent mecha-
nisms [26,27]. That is why we decided to compare how
triggering these nuclear receptors affects the uptake of
apoptotic and necrotic thymocytes by BMDMs. For
this purpose, macrophages were treated with 9cRA
(RXR agonist; Fig. 3A), ATRA (RAR agonist;
Fig. 3B), GW3965 (LXR agonist; Fig. 3C) or dexam-
ethasone (GR agonist; Fig. 3D) for 24 h before expos-
ing them to apoptotic or necrotic thymocytes.
According to our results triggering of all these nuclear
receptors in BMDMs enhances the uptake of both
apoptotic and necrotic thymocytes suggesting that
nuclear receptor ligation-induced phagocytosis enhance-
ment is not restricted only to apoptotic cell uptake.
Apoptotic and necrotic thymocytes compete
with each other during in vitro phagocytosis
If the same receptors participate in the uptake of both
apoptotic and necrotic cells, uptake of the two cell
types should compete with each other. To investigate
this possibility, we performed short-term phagocytosis
competition assays for 30 min in which mouse
BMDMs were fed with differently stained apoptotic
and/or necrotic thymocytes in various apoptotic–
necrotic cell ratios. As shown in Fig. 4A,B, necrotic
thymocytes were engulfed as efficiently as apoptotic
ones, and they competed for the uptake equally well
when added together to macrophages. In contrast,
viable cells are not phagocytosed and they do not
compete with dead cell phagocytosis (Fig. 4C). During
the flow cytometry measurements, we observed, how-
ever, that only a small percentage of macrophages
engulfed both apoptotic and necrotic cells when added
together (Fig. 4D). Therefore, we went on to deter-
mine whether uptake of one cell type influences the
further phagocytic preference of BMDMs.
Macrophages use the same phagocytic portal for
engulfing apoptotic and necrotic cells
During engulfment the phagocytic receptors cluster lat-
erally in the cell membrane forming phagocytic portals
that can be used for the uptake of several apoptotic
cells [24,42,43]. Our observation could indicate that
macrophages form a different phagocytic portal for the
apoptotic and necrotic cells, and once the portal forma-
tion is induced, it will prefer the uptake of the related
cell type. To investigate this possibility, macrophages
were exposed first to fluorescently labeled either apop-
totic or necrotic thymocytes for 30 min. Then they
were washed and exposed to either apoptotic or necro-
tic cells stained differently for an additional 30 min. As
shown in Fig. 5A, we found that within those macro-
phages that already engulfed a target cell, the percent-
age of the uptake of the second cell type was
independent of the previously engulfed cells indicating
that the preassembled phagocytic portals for the two
Fig. 3. Stimulation of nuclear receptors
increases the uptake of both apoptotic and
necrotic thymocytes by BMDMs. BMDMs
were treated with the RXR agonist 9cRA
(A), with the RAR agonist ATRA (B), with
the LXR agonist GW3965 (C) or with the
GR agonist dexamethasone acetate (D) all
in 1 lM concentrations for 24 h. Apoptotic
or necrotic thymocytes were added to
BMDMs in 5 : 1 target cell : macrophage
ratio. Apoptosis and necrosis were
induced as described in Materials and
methods and phagocytosis was allowed
for 60 min. Results are expressed as
mean  SD of three independent
experiments (*significantly different from
its own control, P < 0.05 determined by
unpaired Student’s t test). ns: not
significant.
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target cell type may be similar or the same. Interest-
ingly, the uptake of necrotic cells, when added follow-
ing the prefeeding, was slightly lower as compared to
apoptotic cell phagocytosis, but this lower uptake was
independent of the first cell type taken up. Thus we
concluded that the low simultaneous uptake of apop-
totic and necrotic cells observed in Fig. 4D might be
related to the fact that during the short phagocytic
uptake period mostly only one target cell was taken up
by macrophages.
In order to characterize the internalization mecha-
nisms used by macrophages to engulf apoptotic and
necrotic cells, we studied the morphological character-
istics of BMDMs during phagocytosis by transmission
electron microscopy. During the individual uptake of
both apoptotic and necrotic thymocytes, the engulfing
pseudopods similarly followed tightly the contour of
the target particle (Fig. 5B–C and Fig. S1). Moreover,
the two types of dead cells can be taken up via the
same phagocytic portal (Fig. 5D, Videos S1 and S2,
and Fig. S1A–C) suggesting that similar preassembled
receptor clusters might play a role in their phagocyto-
sis. Previously, experiments using electron microscopic
visualization of early apoptotic and necrotic L929
fibroblast cell phagocytosis demonstrated two different
uptake mechanisms for the uptake of these cells [25].
The apparent contradictions might be resolved by tak-
ing the size of the targets into consideration. L929 cells
Fig. 4. Apoptotic and necrotic thymocytes compete with each other for uptake by BMDMs. (A) Uptake of apoptotic cells in the presence of
increasing amounts of necrotic cells. (B) Uptake of necrotic cells in the presence of increasing amounts of apoptotic cells. (C) Uptake of
apoptotic and necrotic cells in the presence of increasing amounts of viable cells. BMDMs were exposed to differently stained apoptotic
(CFDA-SE), heat-necrotic (deep red) and non-stained viable thymocytes at the indicated ratios. (D) Representative flow cytometry scatter
plots of BMDMs engulfing differently stained target cells at the indicated apoptotic : necrotic cell ratios. The initial number of apoptotic or
necrotic cells was fixed to 1 million and only the amount of the other cell type was increased. Apoptosis and necrosis were induced as
described in Materials and methods. Phagocytosis was allowed for 30 min to make increased phagocytosis detectable even in the presence
of significantly enhanced target cell number. Results are expressed as mean  SD of four independent experiments (*significantly different
from its own control, P < 0.05 determined by unpaired Student’s t test).
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were shown to form small apoptotic bodies that were
surrounded by pseudopods and internalized into tight-
fitting phagosomes while large necrotic cells are
engulfed piece-by-piece via a macropinocytosis-like
process. In our case, the small size of thymocytes, as
compared to L929 cells, might enable the utilization
and formation of similar pseudopods and phagosomes
during apoptotic and necrotic cell uptake.
A key participant of phagocytosis of apoptotic cells
is the small GTPase Rac1, which regulates the redistri-
bution of actin to the membrane ruffles and is acti-
vated by all the phagocytic signaling pathways [21].
Inhibition of Rac1 by the NSC23766 small GTP
binding protein Rac1 inhibitor inhibited the uptake of
necrotic cells as well (Fig. 5E) indicating that not only
the phagocytic receptors, but the signaling pathways
activated by them must be the same in the uptake of
apoptotic and necrotic cells. Altogether our data indi-
cate that both heat- and H2O2-treated necrotic thymo-
cytes express PS and are taken up by PS-dependent
mechanisms, as was indicated previously [22]. We iden-
tified several PS-dependent phagocytic receptors, such
as MerTK, integrins, TG2, and Tim-4, which are
known to participate in the uptake of apoptotic cells,
as participating in necrotic cell uptake as well. Nuclear
receptor stimulation, known to induce the expression
Fig. 5. Apoptotic and necrotic thymocytes are engulfed via the same phagocytic portal and their uptake is Rac1-dependent. (A) BMDMs
were exposed first to either apoptotic or necrotic thymocytes for 30 min, and then these cells were washed away and phagocytosis was
followed with the same amount, but differently stained apoptotic or necrotic cells for an additional 30 min. Apoptosis and necrosis were
induced as described in Materials and methods. The graph shows the fraction of the BMDMs that engulfed the secondly added cells as the
percentage of macrophages that phagocytosed the firstly added target cells. Results are expressed as mean  SD of four independent
experiments. (B–D) Representative transmission electron microscopic images of BMDMs engulfing apoptotic (B), heat-killed necrotic (C)
cells, or both types of dead cells simultaneously (D). (E) BMDMs were treated with the NSC23766 Rac1 inhibitor (100 lM) for 24 h and
subsequently exposed to apoptotic or necrotic thymocytes in 5 : 1 target cell : macrophage ratio. Apoptosis and necrosis were induced as
described in Materials and methods and phagocytosis was allowed for 60 min. Results are expressed as mean  SD of four independent
experiments (*significantly different from its own control, P < 0.05 determined by unpaired Student’s t test). ns: not significant. Scale bar:
2 lm.
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of these phagocytic receptors [26–28] and consequently
the uptake of apoptotic cells, also induced the engulf-
ment of both types of necrotic cells further proving the
involvement of the same phagocytic receptors. Preven-
tion of the necrotic cell uptake by Rac1 inhibition
indicated that not only the receptors, but also the sig-
naling pathways of apoptotic and necrotic cell uptake
are shared. Moreover, the electron microscopic images
also showed that the same phagocytic portals are
opened for the uptake of both apoptotic and necrotic
cells. In accordance, our results also demonstrate that
necrotic cells are engulfed as efficiently as apoptotic
ones and they compete for uptake equally well when
added together to macrophages. What is more, the
uptake of the first cell type (apoptotic or necrotic)
does not decide the preference for the second cell type
taken up. These observations indicate that under
in vivo pathological settings, when very often both
apoptotic and necrotic cells can be detected in the
affected tissue, both cell types will be cleared with sim-
ilar efficiency. Effective clearance of dead cells plays a
central role in the prevention of long-term pathological
events [44,45]. We have recently reviewed the therapeu-
tic possibilities, such as that LXR, peroxisome prolifer-
ator-activated receptor gamma, GR receptor ligation
or macrolide antibiotic administration can enhance the
uptake of apoptotic cells [46]. Our present observa-
tions indicate that many of these approaches might be
effective in stimulating the necrotic cell clearance as
well. Dead cells can be removed not only by profes-
sional phagocytes, but by neighboring non-profes-
sional phagocytes as well. Interestingly, these cells
utilize the same mechanisms for efferocytosis that
macrophages use [47]. To support our findings, admin-
istration of MFG-E8, a bridging molecule that links
dead cell surface PS to the avb3 integrin and its co-
receptor TG2 on the phagocytes [24,41], accelerated
the recovery after myocardial infarction [48], a condi-
tion where necrotic and apoptotic cells were shown to
be engulfed by neighboring cardiac myofibroblast [32].
Conclusions
Altogether our results indicate that primary necrotic
cell phagocytosis seems morphologically similar to
apoptotic cell uptake and the two processes involve
TIM-4, MerTK, integrin avb3, TG2, and Rac1 mole-
cules on the site of macrophages and PS on the dead
cells surface. GR, RAR or LXR receptor activation
augments both necrotic and apoptotic cell clearance,
and therefore clinical therapies targeting apoptotic cell
clearance might also enhance necrotic cell uptake,
which can contribute to the success of these strategies.
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Fig. S1. (A–C) Representative transmission electron
microscopic images of BMDMs engulfing apoptotic
and heat-killed necrotic thymocytes at the same site.
(D–E) Representative transmission electron micro-
scopic images showing that BMDMs form tight-fitting
phagosomes around both the engulfed apoptotic and
heat-killed necrotic thymocytes. Scale bar: 5 lm (A, B)
or 2 lm (C–E).
Video S1. Fluorescence live-cell imaging of apoptotic
and necrotic cell engulfing BMDMs by laser scanning
microscopy. Apoptotic and necrotic thymocytes were
added to BMDMs in 5 : 1 target cell : macrophage
ratio. Apoptosis and necrosis were induced as
described in Materials and methods. Apoptotic thymo-
cytes are labeled with green, necrotic thymocytes with
red and the nuclei of BMDMs with blue colors.
Arrows point to macrophages that took up an apop-
totic and a necrotic cell at the same site.
Video S2. Fluorescence live-cell imaging of apoptotic
and necrotic cell engulfing BMDMs by confocal
microscopy. Apoptotic and necrotic thymocytes were
added to BMDMs in 5 : 1 target cell : macrophage
ratio. Apoptosis and necrosis were induced as
described in Materials and methods. Apoptotic thymo-
cytes are labeled with green, necrotic thymocytes with
blue and BMDMs with red colors. In the middle there
is a macrophage that took up firstly an apoptotic then
a necrotic cell at the same site. Note that apoptotic
and necrotic cells interact at several sites with macro-
phages but uptake happens only at one site.
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